NSE:GLAXO Revenue

In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B INR with 8.56% growth. GlaxoSmithKline Pharmaceuticals had revenue of 9.74B in the quarter ending March 31, 2025, with 4.79% growth.

Revenue

37.49B

Revenue Growth

+8.56%

P/S Ratio

14.84

Revenue / Employee

12.04M

Employees

3,113

Market Cap

556.45B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	37.49B	2.96B	8.56%
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	272.67B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Mankind Pharma	122.07B
Aurobindo Pharma	317.24B
Fortis Healthcare	77.83B

Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

5 weeks ago - Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results - Business Upturn
4 months ago - GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ... - GuruFocus
4 months ago - Q3 2025 GlaxoSmithKline Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
8 months ago - GSK Pharma sets record date for Rs 12 special interim dividend on November 7, 2024 - Business Upturn

More News